These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 21047207)

  • 21. [Therapeutic monitoring of immunosuppressive drugs: interest of calcineurin activity assessment in liver transplantation].
    Blanchet B
    Ann Pharm Fr; 2008 Mar; 66(2):96-101. PubMed ID: 18570908
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Sirolimus monotherapy effectiveness in liver transplant recipients with renal dysfunction due to calcineurin inhibitors.
    Di Benedetto F; Di Sandro S; De Ruvo N; Spaggiari M; Montalti R; Ballarin R; Cappelli G; Gerunda GE
    J Clin Gastroenterol; 2009 Mar; 43(3):280-6. PubMed ID: 19057397
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Calcineurin inhibitors: 40 years later, can't live without ..
    Azzi JR; Sayegh MH; Mallat SG
    J Immunol; 2013 Dec; 191(12):5785-91. PubMed ID: 24319282
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Controversies about the use of calcineurin inhibitors in pediatric patients].
    Dello Strologo L
    G Ital Nefrol; 2008; 25(3):317-24. PubMed ID: 18473303
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Differential expression of tissue factor (TF) in calcineurin inhibitor-induced nephrotoxicity and rejection--implications for development of a possible diagnostic marker.
    Osterholm C; Veress B; Simanaitis M; Hedner U; Ekberg H
    Transpl Immunol; 2005 Dec; 15(2):165-72. PubMed ID: 16412961
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A randomized controlled trial of late conversion from calcineurin inhibitor (CNI)-based to sirolimus-based immunosuppression in liver transplant recipients with impaired renal function.
    Watson CJ; Gimson AE; Alexander GJ; Allison ME; Gibbs P; Smith JC; Palmer CR; Bradley JA
    Liver Transpl; 2007 Dec; 13(12):1694-702. PubMed ID: 18044728
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Calcineurin inhibitor encephalopathy.
    Mammoser A
    Semin Neurol; 2012 Nov; 32(5):517-24. PubMed ID: 23677660
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Calcineurin inhibitors in heart transplantation.
    Keogh A
    J Heart Lung Transplant; 2004 May; 23(5 Suppl):S202-6. PubMed ID: 15093806
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Impact of calcineurin inhibitors on urinary excretion of mycophenolic acid and its glucuronide in kidney transplant recipients.
    Naito T; Mino Y; Otsuka A; Ushiyama T; Ito T; Ozono S; Kagawa Y; Kawakami J
    J Clin Pharmacol; 2009 Jun; 49(6):710-8. PubMed ID: 19451405
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Calcineurin nephrotoxicity.
    Williams D; Haragsim L
    Adv Chronic Kidney Dis; 2006 Jan; 13(1):47-55. PubMed ID: 16412970
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Pharmacology of calcineurin antagonists.
    Kapturczak MH; Meier-Kriesche HU; Kaplan B
    Transplant Proc; 2004 Mar; 36(2 Suppl):25S-32S. PubMed ID: 15041303
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Mechanisms of nephrotoxic action of immunodepressants, calcineurine inhibitors].
    Nikitin AV
    Antibiot Khimioter; 2014; 59(1-2):44-7. PubMed ID: 25051716
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Ten-year protocol biopsy findings of renal allografts in the calcineurin inhibitor era.
    Okamoto M; Akioka K; Ushigome H; Higuchi A; Nobori S; Ogino S; Uryuhara K; Kaihara S; Hatta T; Urasaki K; Yoshimura N
    Clin Transplant; 2006; 20 Suppl 15():16-9. PubMed ID: 16848870
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Effect of immunosuppressive drugs on spontaneous DNA repair in human peripheral blood mononuclear cells.
    Ori Y; Herman-Edelstein M; Zingerman B; Rozen-Zvi B; Gafter U; Malachi T; Gafter-Gvili A
    Biomed Pharmacother; 2012 Sep; 66(6):409-13. PubMed ID: 22795807
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Cytochrome P450 3A5 expression in the kidneys of patients with calcineurin inhibitor nephrotoxicity.
    Joy MS; Hogan SL; Thompson BD; Finn WF; Nickeleit V
    Nephrol Dial Transplant; 2007 Jul; 22(7):1963-8. PubMed ID: 17395652
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The impact of calcineurin inhibitors on graft survival.
    Rush D
    Transplant Rev (Orlando); 2013 Jul; 27(3):93-5. PubMed ID: 23743217
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Late calcineurin inhibitor withdrawal as a strategy to prevent graft loss in patients with suboptimal kidney transplant function.
    Weir MR; Blahut S; Drachenburg C; Young C; Papademitriou J; Klassen DK; Cangro CB; Bartlett ST; Fink JC
    Am J Nephrol; 2004; 24(4):379-86. PubMed ID: 15237243
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Sirolimus in liver transplant recipients with renal dysfunction offers no advantage over low-dose calcineurin inhibitor regimens.
    DuBay D; Smith RJ; Qiu KG; Levy GA; Lilly L; Therapondos G
    Liver Transpl; 2008 May; 14(5):651-9. PubMed ID: 18433069
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Early renal benefit of rapamycin combined with reduced calcineurin inhibitor dose in pediatric heart transplantation patients.
    Balfour IC; Srun SW; Wood EG; Belsha CW; Marshall DL; Ferdman BR
    J Heart Lung Transplant; 2006 May; 25(5):518-22. PubMed ID: 16678029
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Conversion to sirolimus for chronic allograft nephropathy and calcineurin inhibitor toxicity and the adverse effects of sirolimus after conversion.
    Sayin B; Karakayali H; Colak T; Sevmis S; Pehlivan S; Demirhan B; Haberal M
    Transplant Proc; 2009 Sep; 41(7):2789-93. PubMed ID: 19765436
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.